Loading
Argos Therapeutics Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 08 Jan 2016.
Argos Therapeutics Inc: what insiders have been doing
Argos Therapeutics Inc has a thin disclosure history in our data (latest filing: 12 January 2016). New filings will appear here as soon as they are published. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
6
Thresholds
n/a
Buy Volume
n/a
1 ops. · all time
Sell Volume
n/a
n/a
Financial data
as of FY 2017FY ended December 2017 · cache
Income statement
Net income-36.2M
Last declaration on 12 January 2016
Declarations6 total
35,554 sharesCommon StockSEC:0001022855-16-000003:0
28,125 sharesCommon StockSEC:0001543053-16-000002:0
90,401 sharesCommon StockSEC:0001543077-16-000007:0
48,604 sharesCommon StockSEC:0001543209-16-000003:0
32,709 sharesCommon StockSEC:0001556834-16-000008:0
5,000 sharesCommon StockSEC:0001543077-16-000006:0
Canonical exit: 13 Mar 2016 (T+90)
6 of 6 declarations
About Argos Therapeutics Inc
Argos Therapeutics Inc is a biopharmaceutical company focused on developing immunotherapies for the treatment of cancer and other diseases. It is listed on NASDAQ under the ticker ARGS.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
